# Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

> **NCT00152217** · PHASE3 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** TS-1 (S-1)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT00152217
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2007-05
- **Final completion:** 2010-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152217, "Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00152217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*